The private sector's business activity in the United Kingdom (UK) expanded at its fastest pace in eight months in October, ...
Tranche Update on Ascletis Pharma Inc.'s Equity Buyback Plan announced on October 2, 2025. CI Aug. 30 Ascletis Pharma Inc. Doses First Participant In Global Phase III Clinical Program Of Once-Daily ...
(Nasdaq: GILD) will present new clinical and real-world evidence across primary biliary cholangitis (PBC) and chronic ...
InflaRx N.V. announced the presentation of new pre-clinical data on izicopan in renal disease models at the American Society of Nephrology?s Kidney Week 2026, taking place in Denver, Colorado, October ...
Based Electrolytes Held 43.5% Share in 2025 as Demand for Longer EV Range, Fast Charging and Safer Cells Builds, While High Manufacturing Costs and Scalability Hurdles PersistDublin, Oct. 22, 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results